ATE227999T1 - Künstliches mineralwasser für medizinische/prophylaktische zwecke - Google Patents
Künstliches mineralwasser für medizinische/prophylaktische zweckeInfo
- Publication number
- ATE227999T1 ATE227999T1 AT99104298T AT99104298T ATE227999T1 AT E227999 T1 ATE227999 T1 AT E227999T1 AT 99104298 T AT99104298 T AT 99104298T AT 99104298 T AT99104298 T AT 99104298T AT E227999 T1 ATE227999 T1 AT E227999T1
- Authority
- AT
- Austria
- Prior art keywords
- medical
- homeostasis
- mineral water
- prophylactic purposes
- artificial mineral
- Prior art date
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title abstract 2
- 239000011707 mineral Substances 0.000 title abstract 2
- 230000000069 prophylactic effect Effects 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 230000013632 homeostatic process Effects 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 206010018364 Glomerulonephritis Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 210000000232 gallbladder Anatomy 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 238000010606 normalization Methods 0.000 abstract 1
- 238000005457 optimization Methods 0.000 abstract 1
- 239000000049 pigment Substances 0.000 abstract 1
- 230000022558 protein metabolic process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/08—Mineral waters; Sea water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LVP-98-35A LV12343B (lv) | 1998-03-04 | 1998-03-04 | Ārstnieciski profilaktisks ūdens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE227999T1 true ATE227999T1 (de) | 2002-12-15 |
Family
ID=19736416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99104298T ATE227999T1 (de) | 1998-03-04 | 1999-03-03 | Künstliches mineralwasser für medizinische/prophylaktische zwecke |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0941734B1 (de) |
| AT (1) | ATE227999T1 (de) |
| DE (1) | DE69903985T2 (de) |
| EA (1) | EA001269B1 (de) |
| LV (1) | LV12343B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2299728C1 (ru) * | 2005-12-06 | 2007-05-27 | Владимир Дмитриевич Михайлов | Способ профилактики обострения хронического пиелонефрита у беременных женщин |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3139133A1 (de) * | 1981-10-01 | 1983-04-14 | MADE ITALIANA S.r.l., Roma | Pharmazeutische zubereitungen fuer die behandlung der gastrischen hyperaziditaet, der gastritis und gastroduodenaler ulcer |
| RU2099062C1 (ru) * | 1993-02-09 | 1997-12-20 | Индивидуальная частная фирма Научно-исследовательская лаборатория "Асгор" | Минеральная смесь для получения морской воды |
| RU2074723C1 (ru) * | 1994-07-01 | 1997-03-10 | Товарищество с ограниченной ответственностью "Минеральная продукция" | Способ получения искусственно минерализованной воды для наружного применения |
-
1998
- 1998-03-04 LV LVP-98-35A patent/LV12343B/lv unknown
- 1998-06-05 EA EA199800430A patent/EA001269B1/ru not_active IP Right Cessation
-
1999
- 1999-03-03 AT AT99104298T patent/ATE227999T1/de not_active IP Right Cessation
- 1999-03-03 EP EP99104298A patent/EP0941734B1/de not_active Expired - Lifetime
- 1999-03-03 DE DE69903985T patent/DE69903985T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| LV12343B (lv) | 1999-11-20 |
| EA001269B1 (ru) | 2000-12-25 |
| EP0941734B1 (de) | 2002-11-20 |
| EP0941734A2 (de) | 1999-09-15 |
| EP0941734A3 (de) | 1999-09-22 |
| LV12343A (lv) | 1999-09-20 |
| DE69903985T2 (de) | 2003-09-11 |
| DE69903985D1 (de) | 2003-01-02 |
| EA199800430A1 (ru) | 1999-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000066762A3 (en) | Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus | |
| ATE195149T1 (de) | Protein-antagonisten der blut-koagulation und ihre verwendung | |
| DE69721006D1 (de) | Verwendung des modifizierten eigenen blutes zur behandlung von autoimmunerkrankungen | |
| EP1556405A4 (de) | Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert | |
| DE60042137D1 (de) | Rekombinante alpha-l-iduronidase und behandlung von durch diese hervorgerufene mangelerkrankungen | |
| Ascenzi et al. | Proteinase inhibitors from the European medicinal leech Hirudo medicinalis: structural, functional and biomedical aspects | |
| EP1381276A4 (de) | Verfahren zur behandlung oder zur entwicklungsverlangsamung von blindheit | |
| EP0804074A4 (de) | Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen | |
| AU7437494A (en) | A novel physiologically active substance | |
| WO2002074992A3 (en) | Phosphodiesterase 4d genes related to human stroke | |
| ATE444073T1 (de) | Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten | |
| WO2003040183A3 (en) | Compounds for the diagnosis/prevention/treatment of alzheimer's disease | |
| WO2004043990A3 (en) | Human stem cell materials and methods | |
| DE69903985D1 (de) | Künstliches Mineralwasser für medizinische/prophylaktische Zwecke | |
| DK0588118T3 (da) | Carboxypeptidaselignende protein knyttet til knogler samt fremgangsmåde til fremstilling deraf | |
| WO2001004349A3 (en) | Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease | |
| DK360186D0 (da) | Diagnostisk fremgangsmaade til bedoemmelse af kliniske parametre ved direkte samling af biologiske materialer, og organ til udfoerelse af fremgangsmaaden | |
| TR200401952T4 (tr) | Kalp dolaşım hastalıklarının profilaksisi ve tedavisi için hiyaluronidaz'ın kullanımı | |
| AP2009004857A0 (en) | Oxidized proteins, their biological activity, and therapeutic and diagnostic measures,which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof | |
| DE69637715D1 (de) | Synthetische säugetier alpha-n-acetylglukosaminidase und dafür kodierende genetische sequenzen | |
| DK0617023T3 (da) | Benzimidazolderivater, deres fremstilling og anvendelse | |
| WO2004018504A3 (de) | Immunmarker zur diagnostik und therapie im zusammenhang mit transplantat-reaktionen | |
| Burnyasheva et al. | On the question of the treatment of urticaria | |
| Lieberman et al. | Biochemical effects of clozapine in schizophrenia | |
| Markowski et al. | Skin composition in spinal cord injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |